Juno Therapeutics, the Seattle biotech that's creating treatments for late-stage cancer patients, said it's completed raising $176 million in its Series A round of funding. Late last year, Juno, a joint venture between Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center, and Seattle Children's Research Institute — raised $120 million in initial funding and the additional $56 million included investments from Bezos Expeditions, the personal investment company of Amazon.com…
Juno Therapeutics Completes $176m Fund-raising Round; Bezos A Contributor
Ben Miller, Biz Journals
Thu, 04/24/2014 - 6:28am
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more